Real-world implementation of lecanemab and donanemab in an Italian memory center: a 1-year experience - PubMed
5 hours ago
- #Donanemab
- #Lecanemab
- #Alzheimer’s disease
- Real-world implementation of lecanemab and donanemab in an Italian memory center over 1 year.
- Study conducted under Italian regulations with written informed consent from participants.
- Authors report various conflicts of interest including honoraria and research support from pharmaceutical companies.
- References include key clinical trials and regulatory approvals for lecanemab and donanemab.
- Focus on Alzheimer’s disease, amyloid-related imaging abnormalities (ARIA), and plasma biomarkers.